ProMIS Neurosciences, Inc.
PMN
$14.37
$1.8414.65%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 9.52M | -- | 9.37M | 9.80M | 8.75M |
| Gross Profit | -9.52M | -- | -9.37M | -9.80M | -8.75M |
| SG&A Expenses | 2.74M | 1.67M | 1.40M | 1.95M | 1.43M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.27M | 8.64M | 10.77M | 11.75M | 10.18M |
| Operating Income | -12.27M | -8.64M | -10.77M | -11.75M | -10.18M |
| Income Before Tax | -11.73M | -8.24M | -10.67M | -11.58M | -10.12M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.73M | -8.24M | -10.67M | -11.58M | -10.12M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.73M | -8.24M | -10.67M | -11.58M | -10.12M |
| EBIT | -12.27M | -8.64M | -10.77M | -11.75M | -10.18M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -1.28 | -1.26 | -4.14 | -5.93 | -7.26 |
| Normalized Basic EPS | -0.80 | -0.79 | -2.59 | -3.71 | -4.54 |
| EPS Diluted | -1.28 | -1.26 | -4.19 | -6.00 | -7.26 |
| Normalized Diluted EPS | -0.80 | -0.79 | -2.59 | -3.71 | -4.54 |
| Average Basic Shares Outstanding | 9.14M | 6.53M | 2.58M | 1.95M | 1.39M |
| Average Diluted Shares Outstanding | 9.14M | 6.53M | 2.58M | 1.95M | 1.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |